• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Aging . Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older a

tetano

Editor, Senior Moderator
Nat Aging


. 2023 Apr;3(4):418-435.
doi: 10.1038/s43587-023-00379-0. Epub 2023 Mar 13. Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults

Chanchan Xiao[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Zhiyao Ren[SUP] #[/SUP][SUP] 2 4 5 6 7 [/SUP], Bei Zhang[SUP] #[/SUP][SUP] 4 [/SUP], Lipeng Mao[SUP] #[/SUP][SUP] 2 4 [/SUP], Guodong Zhu[SUP] #[/SUP][SUP] 2 5 [/SUP], Lijuan Gao[SUP] 1 2 [/SUP], Jun Su[SUP] 8 [/SUP], Jiezhou Ye[SUP] 1 2 [/SUP], Ze Long[SUP] 1 2 [/SUP], Yue Zhu[SUP] 2 4 [/SUP], Pengfei Chen[SUP] 1 2 [/SUP], Xiangmeng Su[SUP] 1 2 [/SUP], Tong Zhou[SUP] 1 2 [/SUP], Yanhao Huang[SUP] 1 2 [/SUP], Xiongfei Chen[SUP] 9 [/SUP], Chaojun Xie[SUP] 9 [/SUP], Jun Yuan[SUP] 9 [/SUP], Yutian Hu[SUP] 10 [/SUP], Jingshan Zheng[SUP] 11 [/SUP], Zhigang Wang[SUP] 8 [/SUP], Jianrong Lou[SUP] 12 [/SUP], Xiang Yang[SUP] 12 [/SUP], Zhiqiang Kuang[SUP] 8 [/SUP], Hongyi Zhang[SUP] 1 2 [/SUP], Pengcheng Wang[SUP] 13 14 [/SUP], Xiaofeng Liang[SUP] 15 [/SUP], Oscar Junhong Luo[SUP] 16 17 [/SUP], Guobing Chen[SUP] 18 19 20 21 [/SUP]



Affiliations
Abstract

Aging is a critical risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine efficacy. The immune responses to inactivated vaccine for older adults, and the underlying mechanisms of potential differences to young adults, are still unclear. Here we show that neutralizing antibody production by older adults took a longer time to reach similar levels in young adults after inactivated SARS-CoV-2 vaccination. We screened SARS-CoV-2 variant strains for epitopes that stimulate specific CD8 T cell response, and older adults exhibited weaker CD8 T-cell-mediated responses to these epitopes. Comparison of lymphocyte transcriptomes from pre-vaccinated and post-vaccinated donors suggested that the older adults had impaired antigen processing and presentation capability. Single-cell sequencing revealed that older adults had less T cell clone expansion specific to SARS-CoV-2, likely due to inadequate immune receptor repertoire size and diversity. Our study provides mechanistic insights for weaker response to inactivated vaccine by older adults and suggests the need for further vaccination optimization for the old population.


 
Back
Top Bottom